Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 5/20 | 0.46 |
| ▸ | CACNB4 | O00305 | 4/20 | 0.46 |
| ▸ | CACNA1A | O00555 | 4/20 | 0.46 |
| ▸ | CACNA1G | O43497 | 4/20 | 0.46 |
| ▸ | CACNG3 | O60359 | 4/20 | 0.46 |
| ▸ | CACNA1F | O60840 | 4/20 | 0.46 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.46 |
| ▸ | CACNB3 | P54284 | 4/20 | 0.46 |
| ▸ | CACNA2D1 | P54289 | 4/20 | 0.46 |
| ▸ | CACNG7 | P62955 | 4/20 | 0.46 |
| ▸ | CACNA1D | Q01668 | 4/20 | 0.46 |
| ▸ | CACNB1 | Q02641 | 4/20 | 0.46 |
| ▸ | CACNG1 | Q06432 | 4/20 | 0.46 |
| ▸ | CACNB2 | Q08289 | 4/20 | 0.46 |
| ▸ | CACNA1S | Q13698 | 4/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 4/20 | 0.46 |
| ▸ | CACNA1E | Q15878 | 4/20 | 0.46 |
| ▸ | CACNA2D4 | Q7Z3S7 | 4/20 | 0.46 |
| ▸ | CACNA2D3 | Q8IZS8 | 4/20 | 0.46 |
| ▸ | CACNG8 | Q8WXS5 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1198652 | 1.00 | CACNA1B (0.46) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 | |
| SCHEMBL4964658 | 0.99 | CACNA1B (0.44) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 | |
| SCHEMBL4964710 | 0.92 | MEN1 (0.41) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 | |
| SCHEMBL4965952 | 0.91 | HTR6 (0.39) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 | |
| SCHEMBL4964888 | 0.91 | ALDH1A1 (0.42) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 | |
| SCHEMBL14541744 | 0.91 | CACNA1G (0.48) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 | |
| SCHEMBL5427810 | 0.89 | CACNB4 (0.34) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 | |
| SCHEMBL4964497 | 0.89 | CACNB4 (0.35) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 | |
| SCHEMBL4963385 | 0.89 | MEN1 (0.36) | SMN1; SMN2MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL4962978 | 0.87 | HTR2A (0.36) | CACNA1BCACNB4CACNA1ACACNA1GCACNG3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1934220-A1 | INHIBITORS OF THE HIV INTEGRASE ENZYME | Pfizer Products Incorporated (US) | 2008-06-25 | — | — | EP | disclosed |
| US-20070099915-A1 | INHIBITORS OF THE HIV INTEGRASE ENZYME | PFIZER INC. | 2007-05-03 | — | — | US | disclosed |
| US-20070099915-A1 | INHIBITORS OF THE HIV INTEGRASE ENZYME | PFIZER INC. | 2007-05-03 | — | — | US | disclosed |
| US-20070099915-A1 | INHIBITORS OF THE HIV INTEGRASE ENZYME | PFIZER INC. | 2007-05-03 | — | — | US | disclosed |
| WO-2007042883-A1 | INHIBITORS OF THE HIV INTEGRASE ENZYME | PFIZER PRODUCTS INC. (US) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099915-A1 | INHIBITORS OF THE HIV INTEGRASE ENZYME | IMPDH1, INTS9, TYMP | CACNA1B 2999/4885CACNB4 3785/4885CACNA1A 2727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.